iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.267
-0.003 (-0.93%)
At close: May 2, 2024, 3:59 PM
0.265
-0.002 (-0.56%)
After-hours: May 2, 2024, 7:59 PM EDT
iSpecimen Revenue
In the year 2023, iSpecimen had annual revenue of $9.93M, a decrease of -4.56%. Revenue in the quarter ending December 31, 2023 was $2.58M, a -13.05% decrease year-over-year.
Revenue (ttm)
$9.93M
Revenue Growth
-4.56%
P/S Ratio
0.24
Revenue / Employee
$187,324
Employees
53
Market Cap
2.42M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.93M | -474.12K | -4.56% |
Dec 31, 2022 | 10.40M | -733.00K | -6.58% |
Dec 31, 2021 | 11.14M | 2.95M | 36.06% |
Dec 31, 2020 | 8.18M | 3.89M | 90.40% |
Dec 31, 2019 | 4.30M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
cbdMD | 23.45M |
SCWorx | 3.92M |
INVO Bioscience | 3.02M |
Tenon Medical | 2.93M |
Innovative Eyewear | 1.15M |
60 Degrees Pharmaceuticals | 253.57K |
ISPC News
- 7 days ago - iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024 - GlobeNewsWire
- 7 weeks ago - iSpecimen Reports Full Year 2023 Results - GlobeNewsWire
- 7 weeks ago - iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call - GlobeNewsWire
- 2 months ago - iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 - GlobeNewsWire
- 3 months ago - iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research - GlobeNewsWire
- 3 months ago - iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024 - GlobeNewsWire
- 5 months ago - iSpecimen Strengthens Global Oncology Biospecimen Offering - GlobeNewsWire
- 6 months ago - iSpecimen Reports Third Quarter 2023 Financial and Operating Results - GlobeNewsWire